Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06186 | Ipilimumab | 2 | Completed | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06186 | Ipilimumab | 2 | Completed | 1 |